QT Imaging Holdings, Inc.(QTI)

Medical - Devices · Novato, CA

$2.57-0.04 (-1.53%)

Delayed quote: Oct 6, 2026, 3:45 PM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T19:49:03.997Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:49:03.997Z.

Quote observation: 2026-10-06T19:45:24.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 35,386,081
Total debt · period ending 2026-06-30: 4,332,000
Cash · period ending 2026-06-30: 10,974,000
TTM operating EBITDA · period ending 2026-06-30: -4,820,214

FMP input reference: 73a05a26affbff61ca245286eab2f65fbc602d03c7bc752639a64992bef0efba

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

QTI EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

QTI Competitors' EV/EBITDA Ratio

QTI

QT Imaging Holdings, Inc.

Current

Market Cap

$35.39M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELTX

Elicio Therapeutics, Inc.

vs QTI

Market Cap

$35.46M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DCGO

DocGo Inc.

vs QTI

Market Cap

$35.15M

EV/EBITDA Ratio

N/A

TTM Avg

6.76x

3Y Avg

19.14x

5Y Avg

45.56x

BCTX

BriaCell Therapeutics Corp.

vs QTI

Market Cap

$34.89M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EDSA

Edesa Biotech, Inc.

vs QTI

Market Cap

$36.17M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EUDA

EUDA Health Holdings Limited

vs QTI

Market Cap

$36.29M

EV/EBITDA Ratio

N/A

TTM Avg

10986.66x

3Y Avg

10986.66x

5Y Avg

10986.66x

ELUT

Elutia Inc

vs QTI

Market Cap

$34.04M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRCE

Grace Therapeutics, Inc.

vs QTI

Market Cap

$33.85M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALGS

Aligos Therapeutics, Inc.

vs QTI

Market Cap

$33.54M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SCLX

Scilex Holding Company

vs QTI

Market Cap

$33.63M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
QT Imaging Holdings, Inc. (QTI)	$35.39M	N/A	N/A	N/A	N/A
Elicio Therapeutics, Inc. (ELTX)vs ›	$35.46M	N/A	N/A	N/A	N/A
DocGo Inc. (DCGO)vs ›	$35.15M	N/A	6.76x	19.14x	45.56x
BriaCell Therapeutics Corp. (BCTX)vs ›	$34.89M	N/A	N/A	N/A	N/A
Edesa Biotech, Inc. (EDSA)vs ›	$36.17M	N/A	N/A	N/A	N/A
EUDA Health Holdings Limited (EUDA)vs ›	$36.29M	N/A	10986.66x	10986.66x	10986.66x
Elutia Inc (ELUT)vs ›	$34.04M	N/A	N/A	N/A	N/A
Grace Therapeutics, Inc. (GRCE)vs ›	$33.85M	N/A	N/A	N/A	N/A
Aligos Therapeutics, Inc. (ALGS)vs ›	$33.54M	N/A	N/A	N/A	N/A
Scilex Holding Company (SCLX)vs ›	$33.63M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics